This Kansas City, Kansas, advocate calls for Congress to cap out-of-pocket costs at $35 a month. | Opinion ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...

A new study finds Finerenone slows kidney function decline and reduces proteinuria in non-diabetic chronic kidney disease, offering a promising treatment option.

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...

Type 2 diabetes remission is possible with early intervention, significant weight loss and evidence-based care, but it's not ...

A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare ...

Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...

Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025 ...

Despite treatment advances, kidney disease burden remained unchanged over the past decade ...

A 15-year-old Simsboro teen is making history as the first person in Louisiana and the fourth in the world to receive a ...

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.